Research Article
Breast Cancer Immunohistochemistry Features Among Young Women in West Sumatera, Indonesia
@INPROCEEDINGS{10.4108/eai.13-11-2018.2283689, author={Wirsma Arif Harahap and Daan Khambri and Ricvan Dana Nindrea and Husna Yetti}, title={Breast Cancer Immunohistochemistry Features Among Young Women in West Sumatera, Indonesia}, proceedings={Proceedings of the 1st EAI International Conference on Medical And Health Research, ICoMHER November 13-14th 2018, Padang, West Sumatera, Indonesia}, publisher={EAI}, proceedings_a={ICOMHER}, year={2019}, month={5}, keywords={breast cancer immunohistochemistry young women}, doi={10.4108/eai.13-11-2018.2283689} }- Wirsma Arif Harahap
Daan Khambri
Ricvan Dana Nindrea
Husna Yetti
Year: 2019
Breast Cancer Immunohistochemistry Features Among Young Women in West Sumatera, Indonesia
ICOMHER
EAI
DOI: 10.4108/eai.13-11-2018.2283689
Abstract
Breast cancer incidence tends to increase, and it is suggested that it largely contributes to the rise of newly diagnosed cancers among young patients. This study analyzed medical records of patients who belonged to the national health insurance program with breast cancer treatment. The population in this study are all breast cancer patients. Amount of breast cancer among young women is 88 patients. Univariate analysis of the data in this study was used to find the disease-free and overall survival with subtype and stage and bivariate analysis was conducted on these survival statistics using the Kaplan-Meier method and log-rank test. Immunohistochemistry characteristics among young women with breast cancer using chi-square test. A two-tailed P-value of <0.05 was considered statistically significant. Data were analyzed using the Stata version 14.2 (Stata Corporation). But overall survival did not result in a statistically significant (HR = 0.99 (95% CI 0.58-1.70)) with p log rank test > 0.05. There is related significantly breast cancer subtype with the survival of breast cancer patients based on disease-free survival (HR = 1.07 (95% CI 0.62-1.83)) with p log-rank test ≤ 0.05. But overall survival did not result in a statistically significant (HR = 0.99 (95% CI 0.58-1.70)) with p log-rank test > 0.05. This analysis confirmed LVI, stage, KI67, subtype and status is associated with survival breast cancer among young women in West Sumatera, Indonesia
